Literature DB >> 3841020

Intracranial pressure mean arterial pressure and heart rate after rapid paralysis with atracurium in cats.

J P Giffin, B Litwak, J E Cottrell, J Hartung, C Capuano.   

Abstract

The effect of atracurium on intracranial pressure (ICP) was investigated in six cats with normal and increased ICP. The cats were anaesthetized with intraperitoneal pentobarbitone (33 mg . kg-1), acepromazine (0.6 mg . kg-1) and incremental fentanyl (p.r.n. approximately equal to 20 micrograms . kg-1), intubated, and ventilated with nitrous oxide in oxygen. Mean arterial pressure (MAP), heart rate (HR), twitch response and ICP were continuously recorded. After the effect of atracurium had been ascertained under the condition of normal ICP, and after full recovery of twitch response, pH-adjusted Ringer's lactate solution was infused into the cisterna magna until an ICP baseline of 26 +/- 2 mmHg was established and stabilized. Atracurium was then administered again to determine its effect under the condition of elevated ICP. Complete ablation of twitch response was obtained in 68 +/- 15 sec with 0.4 mg . kg-1 atracurium, and there was no significant change in ICP, MAP, HR or cerebral perfusion pressure (CPP) whether initial ICP was normal or elevated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841020     DOI: 10.1007/bf03011408

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  16 in total

1.  Does clinical anesthesia need new neuromuscular blocking agents?

Authors:  J J Savarese; R J Kitz
Journal:  Anesthesiology       Date:  1975-03       Impact factor: 7.892

2.  Effects of d-tubocurarine on intracranial pressure and thalamic electrical impedance.

Authors:  L Tarkkanen; L Laitinen; G Johansson
Journal:  Anesthesiology       Date:  1974-03       Impact factor: 7.892

3.  Control of cerebral perfusion pressure during induction of anesthesia in high-risk neurosurgical patients.

Authors:  C H McLeskey; B F Cullen; R D Kennedy; A Galindo
Journal:  Anesth Analg       Date:  1974 Nov-Dec       Impact factor: 5.108

4.  Clinical comparison of atracurium and vecuronium (Org NC 45).

Authors:  E N Robertson; L H Booij; R J Fragen; J F Crul
Journal:  Br J Anaesth       Date:  1983-02       Impact factor: 9.166

5.  Atracurium in normal doses may release histamine.

Authors:  M A Fox
Journal:  Anesthesiology       Date:  1984-04       Impact factor: 7.892

6.  Succinylcholine and intracranial pressure--a cause for "pause".

Authors:  A M Lam; A W Gelb
Journal:  Anesth Analg       Date:  1984-06       Impact factor: 5.108

7.  The pharmacology of atracurium: a new competitive neuromuscular blocking agent.

Authors:  R Hughes; D J Chapple
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

8.  Comparison of the effects of pancuronium and atracurium on the lower esophageal sphincter.

Authors:  P C Hunt; B R Cotton; G Smith
Journal:  Anesth Analg       Date:  1984-01       Impact factor: 5.108

9.  Atracurium during halothane anesthesia in humans.

Authors:  J A Stirt; A L Murray; R L Katz; D L Schehl; C Lee
Journal:  Anesth Analg       Date:  1983-02       Impact factor: 5.108

10.  Safety and efficacy of atracurium (BW33A) in surgical patients receiving balanced or isoflurane anesthesia.

Authors:  M D Sokoll; S D Gergis; M Mehta; N M Ali; C Lineberry
Journal:  Anesthesiology       Date:  1983-05       Impact factor: 7.892

View more
  3 in total

1.  Evaluation of cerebrospinal fluid lactate and plasma lactate concentrations in anesthetized dogs with and without intracranial disease.

Authors:  Deanne Caines; Melissa Sinclair; Darren Wood; Alexander Valverde; Doris Dyson; Luis Gaitero; Stephanie Nykamp
Journal:  Can J Vet Res       Date:  2013-10       Impact factor: 1.310

Review 2.  Changing practices in neuroanaesthesia.

Authors:  J C Drummond
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 3.  The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review.

Authors:  Filippo Sanfilippo; Cristina Santonocito; Tonny Veenith; Marinella Astuto; Marc O Maybauer
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.